Or Yehuda · Seed–Late Stage · 14 people tracked
Investment thesis
Peregrine Ventures, described as Israel's first dedicated healthcare fund, invests in and supports life science and medical technology companies with the goal of improving patient quality of life. It combines deep industry knowledge with an embedded, synergetic strategy, helping portfolio companies with business, regulatory, and investment strategies. The firm backs companies from seed and early/mid-stage through advanced growth, supporting them in building business strategies, forming strategic alliances, recruiting teams, and bringing healthcare innovations to market. Its dedicated investment vehicles include early and mid-stage funds, the 'Incentive' Incubator, and Peregrine Growth, a fund for mature companies in their final financing rounds before an M&A or IPO.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directoriesWhat they invest in
from 24 of 67 portfolio companiesHealthtech ×17Medical Devices ×17Biotech ×11Digital Health ×5AI & Machine Learning ×4Hardware ×3Robotics ×3Climate Tech ×2
HQs:Israel×9United States×3Nigeria×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×43 founders×2
Investments · 67 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 22021 · 26 dated
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Chaim Lotan(Executive Officer, Director)Ronit Haviv(Executive Officer)David Lifschitz(Director)Ilan Shalom(Executive Officer)Leon Eting(Executive Officer)Itai Katsir(Executive Officer)
Co-investorsPix Vine Capital
Incentive Incubator is a seed-stage incubator in Israel that screens early-stage companies and provides support through a network of business, technology, and strategic experts.
Digital HealthHealthtechMedical DevicesOr Yehuda, IL
Co-investorsPix Vine Capital
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms.
BiotechDeep TechMedical Devices
Co-investorsCancer FocusIsrael Biotech Fund
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investors20/20 HealthCare Partners LLCBosch VenturesNew Era Capital PartnersOrbiMedPitangoQuark Venture Inc.+2 more
Momentis Surgical develops the Anovo Surgical System, a robotic platform designed for minimally-invasive surgery using a transvaginal approach with articulated instruments.
FemTechHealthtechMedical DevicesRoboticsOr Yehuda
Dvir Cohen(Chief Executive Officer)inNataly Fellous(Vice President Finance)inSteven Nunes(Chief Commercial Officer)inHagai Berkovich(Chief Operations Officer)Noam Atar(Chief Financial Officer)in
BoardMorry Blumenfeld(Director)
Board seatLior ShahoryEyal Lifschitz· per SEC Form D
Co-investorsAccelmed Partners
Aleph Farms develops cultivated meat, growing beef steaks from cow cells using tissue engineering technology, and produced the world's first cultivated thin-cut and ribeye steaks.
BiotechClimate TechFoodTech
Neta Lavon(Co-founder & CTO)inShulamit Levenberg(Co-founder)Didier Toubia(Co-founder & CEO)
Co-investorsAlumni VenturesBasecamp FundBloom8Castor Ventures (an Alumni Ventures Fund)Cockpit InnovationStray Dog Capital+3 more
AnserBio develops an oncology biotherapy that restores functional p53 tumor suppressor protein by delivering it through proprietary cell-derived nanovesicles (exosomes).
BiotechDeep TechMedical Devices
Lana Volokh(Co-founder)Alex Tendler(Co-founder)Yevgeny Tendler(CSO)
BioProtect develops a balloon spacer device for brachytherapy procedures, used to create spacing during cancer radiation treatment.
BiotechHealthtechMedical Devices
Itay Barnea(Chief Executive Officer)Derek Webster(Chief Commercial Officer)Lee Adler(Chief Operating Officer)Shahar Shaked(Chief Financial Officer)Dafna Carmi-Yinon(Chief Product and Clinical Officer)
Co-investorsAlmeda VenturesTriventuresMVM Life Science PartnersOlympus Innovation VenturesXenia Venture Capital
Bluefin is an orderbook-based decentralized derivatives exchange built for both first-time users and professional traders.
Crypto & Web3Fintech
Ahmad Jawaid(Founder)in
Co-investorsAltonomyAmber GroupCompoundFBG CapitalHashedLedgerPrime+11 more
Bluewhite develops autonomous unmanned ground vehicle (UGV) technology and physical AI for defense, homeland security, and heavy industrial ground operations.
AI & Machine LearningDefense TechRobotics
Co-investorsEntrée CapitalInsight PartnersAlumni VenturesLIP Ventures
Cardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery.
HardwareHealthtechMedical DevicesOr Yehuda, IL
Developer of implant technology for cartilage and osteochondral defects; sold to Smith and Nephew in 2023.
Co-investorsAccelmed PartnersaMoon
Curesign is a medical device company developing a system that combines sensors with signal processing and big data tools to help oncologists tailor patient-specific cancer treatments.
BiotechHealthtechMedical Devices
EndoStream Medical develops the Nautilus intrasaccular device, a self-conforming scaffold used with coils to treat wide-necked brain aneurysms by maximizing neck coverage and promoting progressive occlusion.
HardwareHealthtechMedical DevicesCaesarea, IL
EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling.
AI & Machine LearningBiotechHealthtechMedical Devices
Eric J. Messika(CEO)Aharon Brodie(CTO)
Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
Boston, US
Evan Witt(Executive Officer, Director)Josh Tayloe(Executive Officer)
Co-investorsAccelmed PartnersTal Ventures
Hairstetics is a medical device company developing synthetic hair implants for treating hair loss, particularly in women.
HealthtechMedical DevicesWellness & Fitness
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.
HealthtechMedical DevicesTirat Carmel
Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in
Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more
Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise.
BiotechDigital HealthHealthtechMedical Devices
Antoni Ribas, M.D., Ph.D.(Founder and Chairman of the Board)Sumant Ramachandra(Chief Executive Officer and Board Director)Jonathan Benjamin(Clinical Development Lead)
Co-investorsaMoonPontifax Venture Capital
Magnisity develops a robotic guidance platform for lung endoscopy that uses patented disposable deformation sensors to provide real-time shape and location navigation inside the body, combining diagnosis and treatment in a single procedure.
HealthtechMedical DevicesRobotics
Benny Greenburg(Co-Founder & CEO)Ron Barak(Co-Founder & CTO)
mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.
B2B MarketplacesDigital HealthHealthtechLogistics & Supply Chain
Co-investors4DX VenturesBreyer CapitalOTVThe Raba PartnershipTimon CapitalJam Fund+2 more
Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery.
HardwareHealthtechMedical DevicesCaesarea, IL
Co-investorsAccelmed Partners
Restore Medical is a medical device company in the cardiology field, developing technology associated with interventional cardiology and cardiac research.
HealthtechMedical DevicesTel Aviv, IL
BoardShmuel Banai(MD, Professor of Cardiology)
BiotechLexington, US
Victoria M. Richon(Executive Officer, Director)in
BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)
Co-investorsAvego BioScience CapitalOUP (Osage University Partners)AbbVieNovartis Venture FundThe Column Group
Wanda Fish develops cell-cultivated seafood, with a flagship cultivated toro bluefin tuna product grown using cell culture and biotechnology methods.
BiotechClimate TechFoodTech
Co-investorsAqua SparkMoreVCCPT CapitalPICO Venture Partners
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
BiotechHealthtechMedical Devices
Guy Yachin(Co-Founder & CEO)Dr. Michael Shtein(Co-Founder & CSO)Prof. Cullen Taniguchi(Co-Founder)
Co-investorsSIBF (Southern Israel Bridging Fund) VC
Portfolio news
latest coverage across their companiesRibon Therapeutics · geekwire.com · Aug 14, 2026
Aleph Farms · calcalistech.com · Jun 2, 2026
Bluewhite · agfundernews.com · May 28, 2026
Cardiovalve · cfrjournal.com · Jan 3, 2026
Mpharma · billionaires.africa · Dec 22, 2025
Hairstetics · prnewswire.com · Oct 22, 2025
Restore Medical · mobihealthnews.com · Jul 8, 2025
Frequently asked questions
- How many investments has Peregrine Ventures made?
- Peregrine Ventures has 63 tracked investments, including 1 dated in the last 24 months.
- What stage does Peregrine Ventures invest at?
- Peregrine Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Peregrine Ventures's typical check size?
- Peregrine Ventures typically writes checks of $500K – $3M.
- What sectors does Peregrine Ventures focus on?
- Peregrine Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Peregrine Ventures located?
- Peregrine Ventures is headquartered in Or Yehuda, IL.
- Who does Peregrine Ventures co-invest with?
- Peregrine Ventures most often shares deals with Accelmed Partners, aMoon, Breyer Capital, among 38 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInvestor Connect - 392 - Eyal Lifschitz of Peregrine Ventures
Hall Martin · Eyal Lifschitz
Images
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.














.jpeg)